Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Start Date
10/16/2025
Completion Date
10/1/2030
Summary
The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.
Detailed Description
The study aims to utilize qualitative measurements, including pre- and post-treatment breast and prostate cancer surveys tailored to specific ethnic groups-Native American, African American, and Hispanic/Latino populations. In addition to these culturally relevant surveys, participants will also complete the COST-Functional Assessment of Chronic Illness Therapy (COST-FACT) score to evaluate the financial and functional impact of their cancer care experience. Those who choose to complete the surveys will be offered navigation assistance as part of the study intervention.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Pre & Post Surveys
Opt Out of Questionnaire
Conditions
Locations
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma 73117
United States